Geary Richard S 4
4 · IONIS PHARMACEUTICALS INC · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Geary Richard S
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2025-11-05$60.89/sh+801$48,773→ 60,458 total - Sale
Common Stock
2025-11-05$75.01/sh−801$60,083→ 59,657 total - Sale
Common Stock
2025-11-06$76.10/sh−14,738$1,121,521→ 59,657 total - Sale
Common Stock
2025-11-06$75.42/sh−18,300$1,380,204→ 59,657 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-06−14,738→ 0 totalExercise: $56.78From: 2024-01-04Exp: 2028-01-03→ Common Stock (14,738 underlying) - Exercise/Conversion
Common Stock
2025-11-05$56.78/sh+800$45,424→ 60,457 total - Sale
Common Stock
2025-11-05$75.01/sh−800$60,008→ 59,657 total - Exercise/Conversion
Common Stock
2025-11-06$56.78/sh+14,738$836,824→ 74,395 total - Exercise/Conversion
Common Stock
2025-11-06$60.89/sh+18,300$1,114,287→ 77,957 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-05−800→ 14,738 totalExercise: $56.78From: 2024-01-04Exp: 2028-01-03→ Common Stock (800 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-05−801→ 18,300 totalExercise: $60.89From: 2023-01-02Exp: 2027-01-01→ Common Stock (801 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-06−18,300→ 0 totalExercise: $60.89From: 2023-01-02Exp: 2027-01-01→ Common Stock (18,300 underlying)
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 6, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.05 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.02 to $75.84 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.84 to $76.65 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) on this Form 4.